Clinical trials: Radiotherapy

Chemotherapy-Induced Nausea and Vomiting (CINV), Radiotherapy-induced Nausea and Vomiting (RINV)

A Study to Compare the Bioavailability of Ondansetron Following Nasal (NS003) and IV Administration in Healthy Adults

• Recruiting
• Age: 18 to 65 years
• Phase 1
• Injection or infusion

A Study to Compare the Bioavailability of Ondansetron Following Nasal (NS003) and IV Administration in Healthy Adults

Conditions

Chemotherapy-Induced Nausea and Vomiting (CINV), Radiotherapy-induced Nausea and Vomiting (RINV), Postoperative Nausea and Vomiting

Trial name

NCT07868861

Testing

NS003 Ondansetron HCl microspheres powder for nasal application, Ondansetron Solution for IV infusion 8mg

Where

Israel

Volunteers

12 people, healthy volunteers welcome

Sponsor

Nasus Pharma